首页> 外文期刊>Archives of environmental health >Multiple chemical sensitivity: a 1999 consensus.
【24h】

Multiple chemical sensitivity: a 1999 consensus.

机译:多种化学敏感性:1999年共识。

获取原文
获取原文并翻译 | 示例
       

摘要

Consensus criteria for the definition of multiple chemical sensitivity (MCS) were first identified in a 1989 multidisciplinary survey of 89 clinicians and researchers with extensive experience in, but widely differing views of, MCS. A decade later, their top 5 consensus criteria (i.e., defining MCS as [1] a chronic condition [2] with symptoms that recur reproducibly [3] in response to low levels of exposure [4] to multiple unrelated chemicals and [5] improve or resolve when incitants are removed) are still unrefuted in published literature. Along with a 6th criterion that we now propose adding (i.e., requiring that symptoms occur in multiple organ systems), these criteria are all commonly encompassed by research definitions of MCS. Nonetheless, their standardized use in clinical settings is still lacking, long overdue, and greatly needed--especially in light of government studies in the United States, United Kingdom, and Canada that revealed 2-4 times as many cases of chemical sensitivity among Gulf War veterans than undeployed controls. In addition, state health department surveys of civilians in New Mexico and California showed that 2-6%, respectively, already had been diagnosed with MCS and that 16% of the civilians reported an "unusual sensitivity" to common everyday chemicals. Given this high prevalence, as well as the 1994 consensus of the American Lung Association, American Medical Association, U.S. Environmental Protection Agency, and the U.S. Consumer Product Safety Commission that "complaints [of MCS] should not be dismissed as psychogenic, and a thorough workup is essential," we recommend that MCS be formally diagnosed--in addition to any other disorders that may be present--in all cases in which the 6 aforementioned consensus criteria are met and no single other organic disorder (e.g., mastocytosis) can account for all the signs and symptoms associated with chemical exposure. The millions of civilians and tens of thousands of Gulf War veterans who suffer from chemical sensitivity should not be kept waiting any longer for a standardized diagnosis while medical research continues to investigate the etiology of their signs and symptoms.
机译:多重化学敏感性(MCS)定义的共识标准是在1989年对89位临床医生和研究人员进行的多学科调查中首次确定的,这些医生和研究人员在MCS方面具有丰富的经验,但意见分歧很大。十年后,他们的最高5项共识标准(即将MCS定义为[1]慢性病[2],其症状可重复出现[3]以应对低水平的接触[4]多种无关化学品和[5]去除煽动者时的改善或解决)仍未在公开文献中反驳。我们现在建议添加的第六条标准(即要求症状出现在多个器官系统中),这些标准通常都包含在MCS的研究定义中。但是,仍然缺乏,长期逾期且非常需要它们在临床环境中的标准化使用-特别是根据美国,英国和加拿大的政府研究表明,海湾地区对化学敏感性的病例是美国的2-4倍退伍军人比未部署的控制人员多。此外,州卫生部门对新墨西哥州和加利福尼亚州的平民进行的调查显示,已经分别诊断出有2-6%的人患有MCS,并且有16%的平民报告对日常的日常化学药品具有“异常的敏感性”。鉴于这种普遍性,以及美国肺病协会,美国医学协会,美国环境保护署和美国消费品安全委员会在1994年达成的共识,“ [MCS]的投诉不应被视为具有心理原因,检查是必不可少的。”我们建议对MCS进行正式诊断-除可能存在的任何其他疾病-在符合上述6个共识标准且没有其他任何器质性疾病(例如肥大细胞增多症)的情况下解释与化学暴露有关的所有体征和症状。在医学研究继续调查其体征和症状的病因时,不应再让数以千计遭受化学敏感性折磨的平民和成千上万的海湾战争退伍军人等待标准化的诊断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号